Terms: = Skin cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4
1709 results:
1. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
[TBL] [Abstract] [Full Text] [Related]
2. Immunoexpression of Ki67, p16 and Beta-catenin in precursor lesions of cutaneous squamous cell carcinoma.
Vîlcea AM; Stoica LE; Andreiana BC; Mirea CS; Ţenea Cojan TŞ; Vîlcea IC; Mărgăritescu C
Rom J Morphol Embryol; 2024; 65(1):19-25. PubMed ID: 38527980
[TBL] [Abstract] [Full Text] [Related]
3. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
[TBL] [Abstract] [Full Text] [Related]
4. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
[TBL] [Abstract] [Full Text] [Related]
5. Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR.
Dobre EG; Nichita L; Popp C; Zurac S; Neagu M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396984
[TBL] [Abstract] [Full Text] [Related]
6. Utility of UV Signature Mutations in the Diagnostic Assessment of Metastatic Head and Neck Carcinomas of Unknown Primary.
Furlan KC; Saeed-Vafa D; Mathew TM; Saller JJ; Tabbara SO; Boyle TA; Wenig BM; Hernandez-Prera JC
Head Neck Pathol; 2024 Feb; 18(1):11. PubMed ID: 38393464
[TBL] [Abstract] [Full Text] [Related]
7. Senescent fibroblast facilitates re-epithelization and collagen deposition in radiation-induced skin injury through IL-33-mediated macrophage polarization.
Chen Y; Ma L; Cheng Z; Hu Z; Xu Y; Wu J; Dai Y; Shi C
J Transl Med; 2024 Feb; 22(1):176. PubMed ID: 38369466
[TBL] [Abstract] [Full Text] [Related]
8. Review: Are moles senescent?
Bennett DC
Pigment Cell Melanoma Res; 2024 May; 37(3):391-402. PubMed ID: 38361107
[TBL] [Abstract] [Full Text] [Related]
9. Genetic testing for familial melanoma.
Primiero CA; Maas EJ; Wallingford CK; Soyer HP; McInerney-Leo AM
Ital J Dermatol Venerol; 2024 Feb; 159(1):34-42. PubMed ID: 38287743
[TBL] [Abstract] [Full Text] [Related]
10. Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary.
Barquín García A; Palacios-Zambrano S; Lozano Alarcón F; Paumard-Hernández B; Quiralte Pulido M; Navarro P; Rodríguez L; Salas Villar I; García-Donas J
J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237079. PubMed ID: 38150820
[TBL] [Abstract] [Full Text] [Related]
11. CD8-Lymphocytic Phenotype Significance in Primary Multiple and Familial Melanoma with Various cdkn2a Mutational Status.
Boşoteanu LA; Gheorghe E; Aşchie M; Cozaru GC; Deacu M; Bălțătescu GI; Orășanu CI; Boşoteanu M
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138255
[No Abstract] [Full Text] [Related]
12. Immunophenotypic p14 and p16 correlations with cdkn2a mutations in primary multiple and familial melanoma: An observational study.
Boşoteanu LA; Gheorghe E; Aşchie M; Cozaru GC; Deacu M; Orășanu CI; Boşoteanu M
Medicine (Baltimore); 2023 Dec; 102(51):e36756. PubMed ID: 38134090
[TBL] [Abstract] [Full Text] [Related]
13. Has-miR-300-GADD45B promotes melanoma growth via cell cycle.
Chen L; Fang C; Yuan X; Liu M; Wu P; Zhong L; Chen Z
Aging (Albany NY); 2023 Dec; 15(23):13920-13943. PubMed ID: 38070141
[TBL] [Abstract] [Full Text] [Related]
14. ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.
Jagirdar K; Portuallo ME; Wei M; Wilhide M; Bravo Narula JA; Robertson BM; Alicea GM; Aguh C; Xiao M; Godok T; Fingerman D; Brown GS; Herlyn M; Elad VM; Guo X; Toska E; Zabransky DJ; Wubbenhorst B; Nathanson KL; Kwatra S; Goyal Y; Ji H; Liu Q; Rebecca VW
Oncogene; 2024 Feb; 43(6):395-405. PubMed ID: 38066089
[TBL] [Abstract] [Full Text] [Related]
15. Melanocytic tumors with spitzoid morphology: correlation of clinicopathologic features and FISH analysis.
Kapişkay DÜ; Ülgen ÖA; İnce Ü; Demirkesen C
Turk J Med Sci; 2023 Aug; 53(4):924-933. PubMed ID: 38031947
[TBL] [Abstract] [Full Text] [Related]
16. Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.
Phillips GS; Mengden-Koon S; Dhossche J; LeBoit PE; Goldstein AM; Lee I; Raffeld M; Papanicolau-Sengos A; Sargen MR; Chung J
J Cutan Pathol; 2024 Mar; 51(3):198-204. PubMed ID: 38031352
[TBL] [Abstract] [Full Text] [Related]
17. Genetic Concordance in Primary Cutaneous Melanoma and Matched Metastasis: A Systematic Review and Meta-Analysis.
Kerkour T; Zhou C; Hollestein L; Mooyaart A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003476
[TBL] [Abstract] [Full Text] [Related]
18. Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization.
Castillo P; Castrejon N; Marginet M; Massi D; Alamon F; Teixido C; Montironi C; Garcia-Herrera A; Albero-Gonzalez R; Matas J; Puig S; Alos L
Clin Exp Dermatol; 2024 Mar; 49(4):356-363. PubMed ID: 37995304
[TBL] [Abstract] [Full Text] [Related]
19. Melanocytic Neoplasm With KIT and APC Mutations: A New Subtype of Melanocytoma?
Donati M; Grossmann P; Mansour B; Kazakov DV
Am J Dermatopathol; 2024 Feb; 46(2):107-110. PubMed ID: 37982490
[TBL] [Abstract] [Full Text] [Related]
20. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients.
Soares de Sá BC; Moredo LF; Torrezan GT; Fidalgo F; de Araújo ÉSS; Formiga MN; Duprat JP; Carraro DM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958811
[TBL] [Abstract] [Full Text] [Related]
[Next]
